Globe Roche Logo

Roche launches the first fully automated CE marked HIV-1/HIV-2 qualitative diagnostic test on cobas® 6800/8800 Systems

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas® HIV-1/HIV-2 for use on the automated cobas® 6800/8800 Systems in countries accepting the CE mark.

Explore

COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0: Qualitative and Quantitative

Accurately detect HCV and confidently monitor viral load results.

More

Roche launches cobas® CT/NG on the cobas® 6800/8800 Systems in markets accepting the CE mark

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE-IVD launch of cobas® CT/NG, for use on the cobas® 6800/8800 Systems for the direct detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) DNA in both symptomatic and asymptomatic individuals. …

Explore

cobas® CT/NG

With STI rates on the rise, cobas® CT/NG provides a solution to meet the growing demand for CT/NG Testing, delivering exceptional assay performance, providing broader information for improved patient care decisions, and enabling simplicity and flexibility to support varying throughput …

More

Roche HIV Global Access Program expands to include next-generation automated platform solutions

High throughput cobas® systems help optimize workflow for resource-limited settings Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion...

Explore

cobas® HIV-1 for use on the cobas® 4800 System

Confidently and effectively quantify HIV-1 using a dual-target approach with cobas® HIV-1 -for the cobas® 4800 System.

More

Human papillomavirus (HPV)

Recent research has identified the Human papillomavirus as the cause of 99 percent of all cervical cancer.

More

Neisseria gonorrhoeae (NG)

Gonococcal infections represent 106 million of the estimated 498 million new cases of curable STIs that occur globally every year.1

More

Herpes simplex virus (HSV-1 and HSV-2)

Herpes is a lifelong infection, which often has mild or no symptoms but can be detected by the presence of antibodies in the blood.

More

Human immunodeficiency virus (HIV)

Learn what’s being done to stop the spread of HIV/AIDS and help the roughly 37 million people around the world currently affected.

More

Chlamydia trachomatis (CT)

Roche supports diagnostic laboratories and healthcare professionals in the swift, accurate detection of Chlamydia and other sexually transmitted infections.1

More

cobas® HCV for use on the cobas® 4800 System

cobas® HCV, quantitative nucleic acid test for use on the cobas® 4800 System, delivers robust, clinically relevant assay performance based on the…

More

cobas® HCV GT for use on the cobas® 4800 System

Test for the qualitative identification of HCV genotypes 1 to 6 and genotype 1 subtypes a and b in…

More

cobas® 4800 CT/NG Test

A qualitative multiplex assay that simultaneously detects two CT independent DNA targets—one in the cryptic plasmid…

More

COBAS® AmpliPrep/COBAS® TaqMan® CMV Test

Real-time, fully automated nucleic acid amplification test to reliably monitor cytomegalovirus (CMV) infection in patients…

More

COBAS® AmpliPrep/COBAS® TaqMan® HBV Test, v2.0

Avoid false positives and increase laboratory efficiency while ensuring confident clinical decisions.

More

COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Qualitative Test

Simple workflow and ready-to-use reagents to support early diagnosis and treatment for improved disease management.

More

COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0

Increase the probability of HIV-1 detection by targeting two highly conserved regions of the HIV-1 genome.

More

COBAS® AmpliScreen HBV Test

A PCR test that detects the presence of HBV DNA in plasma or blood, organ and tissue donors.

More

COBAS® AmpliScreen HCV Test, v2.0

A PCR test that detects the presence of HCV RNA in plasma of blood, organ and tissue donors.

More

COBAS® AmpliScreen HIV-1 Test, v1.5

A polymerase chain reaction (PCR) test for the detection of human immunodeficiency virus type 1 (HIV-1) RNA in human plasma.

More

cobas® HBV for use on the cobas® 6800/8800 System

Get robust, clinically relevant assay performance for optimal results and a highly efficient laboratory workflow.

More

cobas® HCV for use on the cobas® 6800/8800 Systems

Distinguish true signals from background noise leading to more accurate quantification of HCV viral loads.

More

cobas® HEV

Qualitative, real-time PCR test for the direct detection of hepatitis E virus (HEV) in human plasma.

More

cobas® HIV-1 for use on the cobas® 6800/8800 System

Detect HIV-1 variants with dual-target confidence and potentially avoid under-quantification.

More

cobas® HSV 1 and 2 Test

Highly sensitive and specific test designed to reliably detect the presence of HSV-1 and HSV-2 DNA in clinical specimens.

More

cobas® MPX

Detects and discriminates the most critical viral targets in one easy-to-use assay.

More

COBAS® TaqMan® CT Test, v2.0

CT assay simultaneously detects two Chlamydia trachomatis (CT) independent DNA targets.

More

COBAS® TaqMan® HBV Test For Use With The High Pure System 

Hepatitis B virus (HBV) viral load quantification test used in the management of patients with chronic HBV…

More

COBAS® TaqMan® HCV Test v2.0 For Use With The High Pure System

Utilizes real-time PCR technology for the detection and quantitation of HCV RNA genotypes 1-6 as an aid…

More

COBAS® TaqMan® HIV-1 Test, v2.0 For Use With The High Pure System

An advanced and reliable HIV-1 viral load detection with a dual-target approach

More

cobas® TaqScreen MPX Test

A multiplex, real-time PCR test that detects the presence of human immunodeficiency virus type 1 (HIV-1, groups M and O), human immunodeficiency virus type 2 (HIV-2), hepatitis C virus (HCV) and hepatitis B virus…

More

cobas® TaqScreen MPX Test, v2.0

A multiplex, real-time PCR test that offers immediate virus discrimination of HIV, HCV and HBV in donations of human whole blood and blood components including source plasma.

More

cobas® HBV for use on the cobas® 4800 System

Perform HBV viral load testing with a robust and clinically relevant assay for optimal results and a highly efficient laboratory workflow.

More

New Roche HBV Test expands cobas® 4800 System menu 

Complete virology portfolio strengthens high medical value capabilities

Explore

Roche receives FDA approval for HIV-1 viral load test on the cobas® 6800/8800 Systems

HIV-1 test expands menu for highly automated molecular platforms that offer fastest time to results.

Explore

Roche expands cobas® 4800 System menu with HIV-1, HCV and HCV Genotyping Tests

System portfolio broadens to include high medical value virology assays

Explore

Roche receives FDA approval for viral load tests and cobas® 6800/8800 Systems

Roche receives FDA approval for viral load tests and cobas® 6800/8800 Systems. cobas®6800/8800 Systems offer fastest time to results and highest throughput of any molecular platform, helping to improve disease management and patient care.

Explore

Roche expands HIV Global Access Program to include infants in resource limited settings

Program adds early infant testing to further support the  90:90:90 UNAIDS goal

Explore

Roche to provide HIV diagnostic solutions to Global Fund

Framework agreement with Global Fund strengthens access to HIV diagnostics

Explore

Roche receives FDA clearance for the cobas® HSV 1 and 2 Test for the detection of herpes simplex virus

New test expands menu for sexually transmitted infections testing on the cobas® 4800 System

Explore

Roche launches next-generation duplex test for parvovirus B19 and hepatitis A in markets accepting the CE mark

Cobas® DPX assay increases safety of human plasma and plasma products

Explore

Roche launches next-generation viral load assay for HBV in markets accepting the CE mark

Cobas HBV assay offers unparalleled performance on the cobas 6800/8800 Systems

Explore

Roche launches next-generation viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark

cobas HIV-1 and HCV assays offer unparalleled performance on cobas 6800/8800 Systems.

Explore

Roche launches Global Access Program for HIV viral load testing

Program expands access to care supporting the Diagnostics Access Initiative.

Explore

Roche provides HIV diagnostic update at 2014 International AIDS Conference

Novel solutions contribute towards scale up efforts for HIV diagnosis and monitoring

Explore

Roche announces launch of the Dual Target HIV-1 Qualitative Test in markets accepting the CE mark

New test will help increase access for early infant HIV diagnosis.

Explore

Roche announces launch of the cobas® HSV 1 and 2 Test for herpes simplex virus in markets accepting the CE mark

New test expands menu for sexually transmitted infections testing on the cobas® 4800 System.

Explore

Roche receives FDA clearance to use additional specimen types for chlamydia and gonorrhea test

Expanded application for real-time PCR-based test provides laboratories with comprehensive CT/NG test...

Explore

FDA approves new Roche test to evaluate response to hepatitis C therapy

Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies

Explore

Roche announces FDA approval of HIV viral load test

Test is based on innovative dual-target approach

Explore

Roche receives FDA clearance for test to screen and diagnose chlamydia and gonorrhea infection in symptomatic and asymptomatic patients

New cobas CT/NG test expands cobas 4800 system menu beyond clinically proven HPV test to further...

Explore

Roche’s novel tests for the management of hepatitis C virus infection receive CE Mark

Tests change hepatitis C disease and patient management

Explore

New Roche screening test for abacavir hypersensitivity available in Europe

The test confidently detects HLA-B*5701 to help decrease risk of abacavir hypersensitivity reaction

Explore

Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark

cobas® TaqScreen MPX Test, v2.0[1] provides real-time results for HIV, HCV and HBV

Explore

Roche expands use of novel HIV test

Test with enhanced reliability for monitoring HIV patients now CE marked

Explore

Roche submits application for clearance of Chlamydia and Gonorrhoeae test

Test detects and expands menu on the recently approved cobas 4800 instrument

Explore

Roche receives FDA approval for a second-generation hepatitis C viral load test

Another Roche FDA approval in the COBAS® TaqMan® viral load portfolio

Explore

Roche receives FDA approval for second-generation hepatitis B viral load test

Improved viral load testing with a sensitive and fully automated system

Explore

FDA Approves New Roche Dual-PCR Target HIV-1 Test

First dual-PCR target viral load test approved for monitoring HIV patients receiving antiretroviral therapy

Explore

Roche introduces new automated clinical laboratory system for CE-Marked testing of human papillomavirus, Chlamydia and N. gonorrhoeae

New cobas 4800 System designed to increase laboratory efficiency and medical value

Explore

FDA approves use of Roche test to screen source plasma for HIV, hepatitis B virus and hepatitis C virus

cobas® TaqScreen MPX Test is the most comprehensive - detects multiple viruses for increased plasma product safety

Explore

Roche introduces new cobas p 630 Instrument and AMPLILINK 3.3 Series Software with CE Mark

New pre-analytical solution that integrates automated primary tube handling

Explore

FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B &amp, Hepatitis C

Advanced test for increased blood safety is first to add the detection of HIV-1 Group O RNA and HIV-2 RNA

Explore

New Roche Dual Target HIV-1 Test Approved for Use in European Union

Extra confidence and security with an innovative Roche solution

Explore

Improved Testing for Hepatitis B Virus from Roche

A sensitive and fully automated platform improves viral load testing in serum and plasma

Explore

Roche receives FDA approval for Hepatitis C viral load test on its fully automated real-time PCR platform

Improved laboratory efficiencies and standardization to personalize patient care

Explore

FDA Approves First Hepatitis B Viral Load Test

Another Roche first in TaqMan® real-time PCR testing for the diagnostic lab

Explore

New Roche Chlamydia Test Approved for Use in European Union

Test offers more reliable detection of Chlamydia trachomatis, the most commonly reported sexually transmitted disease in Europe.

Explore

Highly sensitive and accurate Roche HIV-1 Test approved by FDA

Automated test enables faster results for doctors monitoring treatment response Roche announced today that the U.S. Food & Drug Administration (FDA) has approved its new HIV-1 test for diagnostic use in the United States. The highly accurate Cobas AmpliPrep/Cobas TaqMan …

Explore

FDA Accepts for Review New Roche Diagnostics Blood Screening Test

Automated test is designed to detect broader range of HIV and hepatitis in a single multiplex assay. Roche Diagnostics announced today that the United States (U.S.) Food & Drug Administration has accepted for review its application for a new test …

Explore

Roche Diagnostics Submits Hepatitis C Viral Load Monitoring Test to FDA

Test designed to give doctors highly accurate results and to improve workflow efficiency for labs Roche Diagnostics announced today that it has submitted its automated test for Hepatitis C viral load monitoring to the U.S. Food & Drug Administration (FDA) …

Explore